SLK expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.41710018456365E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.215600E-04 |
Normal-vs-Stage2 |
1.820440E-03 |
Normal-vs-Stage3 |
2.09054995536917E-13 |
Normal-vs-Stage4 |
4.14845935381436E-12 |
Stage1-vs-Stage2 |
1.625970E-01 |
Stage1-vs-Stage3 |
3.7675000008619E-08 |
Stage1-vs-Stage4 |
2.33159999996069E-06 |
Stage2-vs-Stage3 |
7.449500E-02 |
Stage2-vs-Stage4 |
6.054100E-02 |
Stage3-vs-Stage4 |
7.884400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.36120053801415E-10 |
Normal-vs-AfricanAmerican |
6.25789999999515E-05 |
Normal-vs-Asian |
6.936200E-01 |
Caucasian-vs-AfricanAmerican |
9.516800E-01 |
Caucasian-vs-Asian |
2.148400E-01 |
AfricanAmerican-vs-Asian |
2.082000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.8346990593443E-11 |
Normal-vs-Female |
9.70529999999581E-05 |
Male-vs-Female |
5.637200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.938500E-03 |
Normal-vs-Age(41-60Yrs) |
2.54560000001458E-06 |
Normal-vs-Age(61-80Yrs) |
1.82679982252409E-10 |
Normal-vs-Age(81-100Yrs) |
7.07959999957097E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.792400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.846800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.864800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.896100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.101410E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.479600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.981000E-01 |
Normal-vs-Grade 2 |
2.459300E-03 |
Normal-vs-Grade 3 |
5.60185231535115E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
3.378500E-02 |
Grade 1-vs-Grade 3 |
2.21099999997421E-06 |
Grade 1-vs-Grade 4 |
1.14720000166102E-08 |
Grade 2-vs-Grade 3 |
1.33260000001467E-06 |
Grade 2-vs-Grade 4 |
5.61960478151491E-11 |
Grade 3-vs-Grade 4 |
3.177900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.030400E-02 |
Normal-vs-ccB subtype |
1.85551574105602E-12 |
ccA subtype-vs-ccB subtype |
1.13700004966688E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63840000455551E-08 |
Normal-vs-N1 |
1.72759999994554E-06 |
N0-vs-N1 |
1.468240E-01 |
|
|